- Previous Close
38.90 - Open
42.00 - Bid 40.70 x --
- Ask 40.99 x --
- Day's Range
40.00 - 42.00 - 52 Week Range
35.33 - 51.32 - Volume
21,714 - Avg. Volume
25,177 - Market Cap (intraday)
1.784B - Beta (5Y Monthly) -0.98
- PE Ratio (TTM)
-- - EPS (TTM)
-0.12 - Earnings Date Feb 4, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Syschem (India) Limited manufactures and sells active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. The company's APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. It also engages in the distillation of specialty solvents, such as DMF, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and is based in Chandigarh, India.
www.syschem.in105
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: SYSCHEM.BO
View MorePerformance Overview: SYSCHEM.BO
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SYSCHEM.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SYSCHEM.BO
View MoreValuation Measures
Market Cap
1.69B
Enterprise Value
1.69B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.48
Price/Book (mrq)
3.00
Enterprise Value/Revenue
0.53
Enterprise Value/EBITDA
44.16
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.08%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
3.36B
Net Income Avi to Common (ttm)
-2.64M
Diluted EPS (ttm)
-0.12
Balance Sheet and Cash Flow
Total Cash (mrq)
1.01M
Total Debt/Equity (mrq)
0.22%
Levered Free Cash Flow (ttm)
--